Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001288601 | SCV001475852 | uncertain significance | not provided | 2020-02-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001288601 | SCV001961162 | likely pathogenic | not provided | 2021-08-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001288601 | SCV003269748 | pathogenic | not provided | 2023-12-18 | criteria provided, single submitter | clinical testing | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 341 of the FLVCR1 protein (p.Tyr341Cys). This variant is present in population databases (rs200151282, gnomAD 0.008%). This missense change has been observed in individual(s) with retinitis pigmentosa (PMID: 31884612). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 994874). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001288601 | SCV004031839 | uncertain significance | not provided | 2023-08-19 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31884612, 35055178, 29192808, 34931442) |